MII
Mii is a venture capital firm that specializes in investing in dermatology-related technologies in various sectors including pharma, biotech, medical devices, digital health, and cosmetics. With a focus on seed to growth stage companies, Mii partners with Maruho, a leading dermatology company in Japan, to introduce Israeli innovations in dermatology and skin care to the Japanese market. By leveraging this partnership, Mii aims to provide Japan with access to cutting-edge skin therapies and advance the field of dermatology globally.
Top Stages
1 past transactions
MyBiotics Pharma
Venture Round in 2021
MyBiotics is a developer of innovative live bacteria-based therapeutics aimed at enhancing human health through microbiome restoration. The company has pioneered technologies such as MyCrobeTM and SuperDonorTM, which address key challenges in probiotic development including delivery, targeting, and colonization. These technologies facilitate both single and multi-bacterial combinations for targeted treatments and comprehensive microbiome restoration. Additionally, MyBiotics has created a screening method intended to replace traditional fecal microbiota transplants. By focusing on the restoration of a healthy bacterial population, MyBiotics aims to establish a competitive balance against disease-promoting bacteria, thereby improving overall health outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.